Drug profile · INN
cisatracurium besylate
CISATRACURIUM BESYLATE
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
cisatracurium besylate (CISATRACURIUM BESYLATE) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN cisatracurium besylate
Brand CISATRACURIUM BESYLATE
Route INJECTION
Formulation INJECTABLE
Frequently asked questions
What is cisatracurium besylate?
cisatracurium besylate (CISATRACURIUM BESYLATE) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for cisatracurium besylate?
CISATRACURIUM BESYLATE is a marketed brand name for cisatracurium besylate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of cisatracurium besylate?
cisatracurium besylate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.